The HSI inched up 99 points or 0.4% to close at 23,381. The HSCEI lifted 32 points or 0.4% to close at 8,469. The HSTECH added 24 points or 0.5% to close at 5,182. Total market turnover for the day amounted to $203.268 billion.

MEITUAN-W (03690.HK)  -2.800 (-1.986%)    Short selling $1.94B; Ratio 24.393%   reported a 46.2% YoY hike in 1Q non-IFRS adjusted profit, beating expectations, but warned of a YoY plunge in core local commerce operating profit for 2Q. MEITUAN-W once cratered 5.5%, and closed up 2.1% at $132.1. JD-SW (09618.HK)  -1.600 (-1.218%)    Short selling $1.13B; Ratio 36.038%   dropped 1% to $128.3, while BABA-W (09988.HK)  -2.600 (-2.269%)    Short selling $1.57B; Ratio 11.475%   picked up 0.9% to $118. The meeting of the State Council's Anti-Monopoly and Anti-Unfair Competition Committee Expert Advisory Group was recently held in Beijing to address 'involutionary' competition.

Pharma elevated. GENSCRIPT BIO (01548.HK)  -0.720 (-4.245%)    Short selling $92.17M; Ratio 10.390%   , INNOVENT BIO (01801.HK)  -0.050 (-0.062%)    Short selling $401.73M; Ratio 14.116%   , CSPC PHARMA (01093.HK)  -0.210 (-2.320%)    Short selling $230.55M; Ratio 9.053%   , LUYE PHARMA (02186.HK)  +0.100 (+2.618%)    Short selling $106.02M; Ratio 9.642%   and PHARMARON (03759.HK)  +0.220 (+1.288%)    Short selling $19.19M; Ratio 7.255%   advanced 5.3-6.5%, while SINO BIOPHARM (01177.HK)  -0.160 (-2.812%)    Short selling $176.68M; Ratio 8.168%   and HANSOH PHARMA (03692.HK)  -0.500 (-1.672%)    Short selling $86.58M; Ratio 18.038%   leaped 4.7 and 3.7%. Listed IPO HENGRUI PHARMA (01276.HK)  -1.500 (-2.530%)   climbed 2.2%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-13 16:25.)